nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Temsirolimus—kidney cancer	0.0918	0.113	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0918	0.113	CbGbCtD
Dextropropoxyphene—CYP2D6—Temsirolimus—kidney cancer	0.0422	0.0522	CbGbCtD
Dextropropoxyphene—CYP3A4—Everolimus—kidney cancer	0.0398	0.0491	CbGbCtD
Dextropropoxyphene—CYP2C8—Pazopanib—kidney cancer	0.0348	0.043	CbGbCtD
Dextropropoxyphene—CYP3A7—Paclitaxel—kidney cancer	0.0315	0.0389	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0315	0.0389	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.028	0.0346	CbGbCtD
Dextropropoxyphene—CYP3A7—Sorafenib—kidney cancer	0.028	0.0346	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0272	0.0336	CbGbCtD
Dextropropoxyphene—CYP3A7—Vincristine—kidney cancer	0.0272	0.0336	CbGbCtD
Dextropropoxyphene—CYP3A4—Temsirolimus—kidney cancer	0.0269	0.0332	CbGbCtD
Dextropropoxyphene—CYP2C9—Capecitabine—kidney cancer	0.0253	0.0313	CbGbCtD
Dextropropoxyphene—CYP2C8—Erlotinib—kidney cancer	0.0248	0.0307	CbGbCtD
Dextropropoxyphene—CYP2C8—Paclitaxel—kidney cancer	0.0227	0.0281	CbGbCtD
Dextropropoxyphene—CYP3A7—Sunitinib—kidney cancer	0.0227	0.028	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0227	0.028	CbGbCtD
Dextropropoxyphene—CYP2D6—Pazopanib—kidney cancer	0.0222	0.0274	CbGbCtD
Dextropropoxyphene—CYP2C8—Sorafenib—kidney cancer	0.0202	0.0249	CbGbCtD
Dextropropoxyphene—CYP2C9—Paclitaxel—kidney cancer	0.0159	0.0196	CbGbCtD
Dextropropoxyphene—CYP2D6—Erlotinib—kidney cancer	0.0158	0.0196	CbGbCtD
Dextropropoxyphene—CYP3A4—Pazopanib—kidney cancer	0.0141	0.0174	CbGbCtD
Dextropropoxyphene—CYP2C9—Sorafenib—kidney cancer	0.0141	0.0174	CbGbCtD
Dextropropoxyphene—CYP2D6—Sorafenib—kidney cancer	0.0129	0.0159	CbGbCtD
Dextropropoxyphene—CYP2D6—Vinblastine—kidney cancer	0.0127	0.0157	CbGbCtD
Dextropropoxyphene—CYP3A4—Erlotinib—kidney cancer	0.0101	0.0124	CbGbCtD
Dextropropoxyphene—CYP3A4—Paclitaxel—kidney cancer	0.00922	0.0114	CbGbCtD
Dextropropoxyphene—CYP3A4—Sorafenib—kidney cancer	0.00819	0.0101	CbGbCtD
Dextropropoxyphene—CYP3A4—Vinblastine—kidney cancer	0.00809	0.00998	CbGbCtD
Dextropropoxyphene—CYP3A4—Vincristine—kidney cancer	0.00795	0.00982	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—kidney cancer	0.00781	0.00965	CbGbCtD
Dextropropoxyphene—CYP3A4—Sunitinib—kidney cancer	0.00663	0.00819	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—kidney cancer	0.00497	0.00613	CbGbCtD
Dextropropoxyphene—Dimetacrine—ACHE—kidney cancer	0.00117	0.274	CrCbGaD
Dextropropoxyphene—Loperamide—POMC—kidney cancer	0.000945	0.222	CrCbGaD
Dextropropoxyphene—CYP2C9—urine—kidney cancer	0.000391	0.158	CbGeAlD
Dextropropoxyphene—Immune system disorder—Gemcitabine—kidney cancer	0.000383	0.00222	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Sorafenib—kidney cancer	0.000382	0.00221	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Gemcitabine—kidney cancer	0.000382	0.00221	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Erlotinib—kidney cancer	0.000381	0.00221	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP1A1—kidney cancer	0.000381	0.0895	CrCbGaD
Dextropropoxyphene—Rash—Temsirolimus—kidney cancer	0.000381	0.00221	CcSEcCtD
Dextropropoxyphene—Dermatitis—Temsirolimus—kidney cancer	0.00038	0.0022	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Gemcitabine—kidney cancer	0.000378	0.00219	CcSEcCtD
Dextropropoxyphene—Headache—Temsirolimus—kidney cancer	0.000378	0.00219	CcSEcCtD
Dextropropoxyphene—Dizziness—Pazopanib—kidney cancer	0.000376	0.00218	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000374	0.00217	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000374	0.00216	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—kidney cancer	0.000374	0.00216	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Vinblastine—kidney cancer	0.000371	0.00215	CcSEcCtD
Dextropropoxyphene—Constipation—Erlotinib—kidney cancer	0.000371	0.00215	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Everolimus—kidney cancer	0.00037	0.00214	CcSEcCtD
Dextropropoxyphene—Shock—Sunitinib—kidney cancer	0.000369	0.00214	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Vinblastine—kidney cancer	0.000369	0.00214	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Sunitinib—kidney cancer	0.000368	0.00213	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Everolimus—kidney cancer	0.000367	0.00213	CcSEcCtD
Dextropropoxyphene—Discomfort—Dactinomycin—kidney cancer	0.000366	0.00212	CcSEcCtD
Dextropropoxyphene—Vomiting—Pazopanib—kidney cancer	0.000362	0.00209	CcSEcCtD
Dextropropoxyphene—Bradycardia—Paclitaxel—kidney cancer	0.000361	0.00209	CcSEcCtD
Dextropropoxyphene—Rash—Pazopanib—kidney cancer	0.000359	0.00208	CcSEcCtD
Dextropropoxyphene—Nausea—Temsirolimus—kidney cancer	0.000359	0.00208	CcSEcCtD
Dextropropoxyphene—Dermatitis—Pazopanib—kidney cancer	0.000358	0.00208	CcSEcCtD
Dextropropoxyphene—Agitation—Vincristine—kidney cancer	0.000357	0.00207	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Vinblastine—kidney cancer	0.000356	0.00206	CcSEcCtD
Dextropropoxyphene—Headache—Pazopanib—kidney cancer	0.000356	0.00206	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Everolimus—kidney cancer	0.000355	0.00206	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Erlotinib—kidney cancer	0.000354	0.00205	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Sorafenib—kidney cancer	0.000348	0.00201	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Sorafenib—kidney cancer	0.000343	0.00199	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Erlotinib—kidney cancer	0.000343	0.00198	CcSEcCtD
Dextropropoxyphene—Visual impairment—Paclitaxel—kidney cancer	0.000342	0.00198	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—kidney cancer	0.000341	0.00198	CcSEcCtD
Dextropropoxyphene—Insomnia—Sunitinib—kidney cancer	0.000339	0.00197	CcSEcCtD
Dextropropoxyphene—Nausea—Pazopanib—kidney cancer	0.000338	0.00196	CcSEcCtD
Dextropropoxyphene—Convulsion—Vincristine—kidney cancer	0.000337	0.00195	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000337	0.00195	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Sunitinib—kidney cancer	0.000334	0.00194	CcSEcCtD
Dextropropoxyphene—Constipation—Sorafenib—kidney cancer	0.000333	0.00193	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Vinblastine—kidney cancer	0.000332	0.00192	CcSEcCtD
Dextropropoxyphene—Eye disorder—Paclitaxel—kidney cancer	0.000331	0.00192	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Everolimus—kidney cancer	0.000331	0.00192	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Sunitinib—kidney cancer	0.00033	0.00191	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Paclitaxel—kidney cancer	0.000329	0.00191	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000324	0.00188	CcSEcCtD
Dextropropoxyphene—Asthenia—Vinblastine—kidney cancer	0.000323	0.00187	CcSEcCtD
Dextropropoxyphene—Asthenia—Everolimus—kidney cancer	0.000322	0.00187	CcSEcCtD
Dextropropoxyphene—Constipation—Sunitinib—kidney cancer	0.000321	0.00186	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Paclitaxel—kidney cancer	0.00032	0.00186	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Paclitaxel—kidney cancer	0.00032	0.00185	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Capecitabine—kidney cancer	0.00032	0.00185	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Sorafenib—kidney cancer	0.000319	0.00185	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Capecitabine—kidney cancer	0.000318	0.00184	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Paclitaxel—kidney cancer	0.000317	0.00184	CcSEcCtD
Dextropropoxyphene—Jaundice—Capecitabine—kidney cancer	0.000316	0.00183	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—PTGS1—kidney cancer	0.000314	0.0738	CrCbGaD
Dextropropoxyphene—Nervous system disorder—Vincristine—kidney cancer	0.000311	0.0018	CcSEcCtD
Dextropropoxyphene—Asthenia—Erlotinib—kidney cancer	0.000311	0.0018	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—kidney cancer	0.00031	0.0018	CcSEcCtD
Dextropropoxyphene—Discomfort—Gemcitabine—kidney cancer	0.00031	0.0018	CcSEcCtD
Dextropropoxyphene—Malnutrition—Paclitaxel—kidney cancer	0.000309	0.00179	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vinblastine—kidney cancer	0.000308	0.00179	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Sorafenib—kidney cancer	0.000308	0.00179	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Everolimus—kidney cancer	0.000307	0.00178	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Sunitinib—kidney cancer	0.000307	0.00178	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Capecitabine—kidney cancer	0.000307	0.00178	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000299	0.00173	CcSEcCtD
Dextropropoxyphene—CYP3A4—urine—kidney cancer	0.000298	0.12	CbGeAlD
Dextropropoxyphene—Dizziness—Vinblastine—kidney cancer	0.000298	0.00173	CcSEcCtD
Dextropropoxyphene—Dizziness—Everolimus—kidney cancer	0.000297	0.00172	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Sunitinib—kidney cancer	0.000296	0.00172	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Erlotinib—kidney cancer	0.000296	0.00172	CcSEcCtD
Dextropropoxyphene—Hypotension—Vincristine—kidney cancer	0.000296	0.00172	CcSEcCtD
Dextropropoxyphene—Bradycardia—Capecitabine—kidney cancer	0.000296	0.00172	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Gemcitabine—kidney cancer	0.000295	0.00171	CcSEcCtD
Dextropropoxyphene—CYP2D6—urine—kidney cancer	0.000293	0.119	CbGeAlD
Dextropropoxyphene—Feeling abnormal—Dactinomycin—kidney cancer	0.000293	0.0017	CcSEcCtD
Dextropropoxyphene—Vision blurred—Paclitaxel—kidney cancer	0.000291	0.00169	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00029	0.00168	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Sorafenib—kidney cancer	0.000287	0.00166	CcSEcCtD
Dextropropoxyphene—Insomnia—Vincristine—kidney cancer	0.000287	0.00166	CcSEcCtD
Dextropropoxyphene—Vomiting—Vinblastine—kidney cancer	0.000287	0.00166	CcSEcCtD
Dextropropoxyphene—Dizziness—Erlotinib—kidney cancer	0.000287	0.00166	CcSEcCtD
Dextropropoxyphene—Vomiting—Everolimus—kidney cancer	0.000286	0.00165	CcSEcCtD
Dextropropoxyphene—Agitation—Paclitaxel—kidney cancer	0.000284	0.00164	CcSEcCtD
Dextropropoxyphene—Rash—Everolimus—kidney cancer	0.000283	0.00164	CcSEcCtD
Dextropropoxyphene—Dermatitis—Everolimus—kidney cancer	0.000283	0.00164	CcSEcCtD
Dextropropoxyphene—Headache—Vinblastine—kidney cancer	0.000282	0.00164	CcSEcCtD
Dextropropoxyphene—Headache—Everolimus—kidney cancer	0.000281	0.00163	CcSEcCtD
Dextropropoxyphene—Hypotension—Gemcitabine—kidney cancer	0.000281	0.00163	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Dactinomycin—kidney cancer	0.000281	0.00163	CcSEcCtD
Dextropropoxyphene—Visual impairment—Capecitabine—kidney cancer	0.00028	0.00162	CcSEcCtD
Dextropropoxyphene—Asthenia—Sorafenib—kidney cancer	0.00028	0.00162	CcSEcCtD
Dextropropoxyphene—Syncope—Paclitaxel—kidney cancer	0.000277	0.0016	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Sunitinib—kidney cancer	0.000276	0.0016	CcSEcCtD
Dextropropoxyphene—Vomiting—Erlotinib—kidney cancer	0.000275	0.0016	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Vincristine—kidney cancer	0.000274	0.00159	CcSEcCtD
Dextropropoxyphene—Rash—Erlotinib—kidney cancer	0.000273	0.00158	CcSEcCtD
Dextropropoxyphene—Dermatitis—Erlotinib—kidney cancer	0.000273	0.00158	CcSEcCtD
Dextropropoxyphene—Insomnia—Gemcitabine—kidney cancer	0.000272	0.00158	CcSEcCtD
Dextropropoxyphene—Eye disorder—Capecitabine—kidney cancer	0.000272	0.00158	CcSEcCtD
Dextropropoxyphene—Headache—Erlotinib—kidney cancer	0.000271	0.00157	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Paclitaxel—kidney cancer	0.000271	0.00157	CcSEcCtD
Dextropropoxyphene—Constipation—Vincristine—kidney cancer	0.000271	0.00157	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000271	0.00157	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Capecitabine—kidney cancer	0.00027	0.00156	CcSEcCtD
Dextropropoxyphene—Asthenia—Sunitinib—kidney cancer	0.000269	0.00156	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Gemcitabine—kidney cancer	0.000268	0.00155	CcSEcCtD
Dextropropoxyphene—Nausea—Vinblastine—kidney cancer	0.000268	0.00155	CcSEcCtD
Dextropropoxyphene—Somnolence—Gemcitabine—kidney cancer	0.000268	0.00155	CcSEcCtD
Dextropropoxyphene—Convulsion—Paclitaxel—kidney cancer	0.000267	0.00155	CcSEcCtD
Dextropropoxyphene—Nausea—Everolimus—kidney cancer	0.000267	0.00155	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Sorafenib—kidney cancer	0.000267	0.00155	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Capecitabine—kidney cancer	0.000263	0.00152	CcSEcCtD
Dextropropoxyphene—OPRD1—renal system—kidney cancer	0.000263	0.106	CbGeAlD
Dextropropoxyphene—Mediastinal disorder—Capecitabine—kidney cancer	0.000262	0.00152	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Dactinomycin—kidney cancer	0.000262	0.00152	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Capecitabine—kidney cancer	0.00026	0.00151	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00026	0.00151	CcSEcCtD
Dextropropoxyphene—Discomfort—Paclitaxel—kidney cancer	0.00026	0.0015	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Vincristine—kidney cancer	0.000259	0.0015	CcSEcCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000258	0.104	CbGeAlD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—kidney cancer	0.000258	0.00149	CcSEcCtD
Dextropropoxyphene—Dizziness—Sorafenib—kidney cancer	0.000258	0.00149	CcSEcCtD
Dextropropoxyphene—Constipation—Gemcitabine—kidney cancer	0.000257	0.00149	CcSEcCtD
Dextropropoxyphene—Nausea—Erlotinib—kidney cancer	0.000257	0.00149	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Sunitinib—kidney cancer	0.000257	0.00149	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—kidney cancer	0.000255	0.00148	CcSEcCtD
Dextropropoxyphene—Asthenia—Dactinomycin—kidney cancer	0.000255	0.00148	CcSEcCtD
Dextropropoxyphene—Confusional state—Paclitaxel—kidney cancer	0.000254	0.00147	CcSEcCtD
Dextropropoxyphene—OPRD1—kidney—kidney cancer	0.000254	0.103	CbGeAlD
Dextropropoxyphene—Malnutrition—Capecitabine—kidney cancer	0.000253	0.00147	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Vincristine—kidney cancer	0.000251	0.00145	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—kidney cancer	0.00025	0.00145	CcSEcCtD
Dextropropoxyphene—Dizziness—Sunitinib—kidney cancer	0.000248	0.00144	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Gemcitabine—kidney cancer	0.000248	0.00144	CcSEcCtD
Dextropropoxyphene—Shock—Paclitaxel—kidney cancer	0.000248	0.00144	CcSEcCtD
Dextropropoxyphene—Vomiting—Sorafenib—kidney cancer	0.000248	0.00144	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Paclitaxel—kidney cancer	0.000247	0.00143	CcSEcCtD
Dextropropoxyphene—Tachycardia—Paclitaxel—kidney cancer	0.000246	0.00142	CcSEcCtD
Dextropropoxyphene—Rash—Sorafenib—kidney cancer	0.000246	0.00142	CcSEcCtD
Dextropropoxyphene—Dermatitis—Sorafenib—kidney cancer	0.000246	0.00142	CcSEcCtD
Dextropropoxyphene—Headache—Sorafenib—kidney cancer	0.000244	0.00141	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Dactinomycin—kidney cancer	0.000243	0.00141	CcSEcCtD
Dextropropoxyphene—Vision blurred—Capecitabine—kidney cancer	0.000239	0.00138	CcSEcCtD
Dextropropoxyphene—Vomiting—Sunitinib—kidney cancer	0.000238	0.00138	CcSEcCtD
Dextropropoxyphene—Rash—Sunitinib—kidney cancer	0.000236	0.00137	CcSEcCtD
Dextropropoxyphene—Dermatitis—Sunitinib—kidney cancer	0.000236	0.00137	CcSEcCtD
Dextropropoxyphene—Hypotension—Paclitaxel—kidney cancer	0.000235	0.00136	CcSEcCtD
Dextropropoxyphene—Headache—Sunitinib—kidney cancer	0.000235	0.00136	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Vincristine—kidney cancer	0.000234	0.00135	CcSEcCtD
Dextropropoxyphene—Nausea—Sorafenib—kidney cancer	0.000232	0.00134	CcSEcCtD
Dextropropoxyphene—Insomnia—Paclitaxel—kidney cancer	0.000228	0.00132	CcSEcCtD
Dextropropoxyphene—Asthenia—Vincristine—kidney cancer	0.000228	0.00132	CcSEcCtD
Dextropropoxyphene—Syncope—Capecitabine—kidney cancer	0.000227	0.00132	CcSEcCtD
Dextropropoxyphene—Vomiting—Dactinomycin—kidney cancer	0.000226	0.00131	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Paclitaxel—kidney cancer	0.000225	0.0013	CcSEcCtD
Dextropropoxyphene—Somnolence—Paclitaxel—kidney cancer	0.000224	0.0013	CcSEcCtD
Dextropropoxyphene—Rash—Dactinomycin—kidney cancer	0.000224	0.0013	CcSEcCtD
Dextropropoxyphene—Nausea—Sunitinib—kidney cancer	0.000223	0.00129	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Capecitabine—kidney cancer	0.000223	0.00129	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Paclitaxel—kidney cancer	0.000222	0.00128	CcSEcCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000221	0.0894	CbGeAlD
Dextropropoxyphene—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000218	0.00126	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vincristine—kidney cancer	0.000217	0.00126	CcSEcCtD
Dextropropoxyphene—Asthenia—Gemcitabine—kidney cancer	0.000216	0.00125	CcSEcCtD
Dextropropoxyphene—Constipation—Paclitaxel—kidney cancer	0.000215	0.00125	CcSEcCtD
Dextropropoxyphene—Discomfort—Capecitabine—kidney cancer	0.000213	0.00123	CcSEcCtD
Dextropropoxyphene—Nausea—Dactinomycin—kidney cancer	0.000211	0.00122	CcSEcCtD
Dextropropoxyphene—Dizziness—Vincristine—kidney cancer	0.00021	0.00122	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—kidney cancer	0.000209	0.00121	CcSEcCtD
Dextropropoxyphene—Confusional state—Capecitabine—kidney cancer	0.000208	0.00121	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Paclitaxel—kidney cancer	0.000208	0.0012	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000206	0.00119	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Gemcitabine—kidney cancer	0.000206	0.00119	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—kidney cancer	0.000204	0.00118	CcSEcCtD
Dextropropoxyphene—Shock—Capecitabine—kidney cancer	0.000203	0.00118	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Capecitabine—kidney cancer	0.000203	0.00117	CcSEcCtD
Dextropropoxyphene—Toremifene—ABCB1—kidney cancer	0.000203	0.0476	CrCbGaD
Dextropropoxyphene—Tachycardia—Capecitabine—kidney cancer	0.000202	0.00117	CcSEcCtD
Dextropropoxyphene—Vomiting—Vincristine—kidney cancer	0.000202	0.00117	CcSEcCtD
Dextropropoxyphene—Rash—Vincristine—kidney cancer	0.0002	0.00116	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vincristine—kidney cancer	0.0002	0.00116	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Paclitaxel—kidney cancer	0.000199	0.00115	CcSEcCtD
Dextropropoxyphene—Headache—Vincristine—kidney cancer	0.000199	0.00115	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000198	0.00115	CcSEcCtD
Dextropropoxyphene—Hypotension—Capecitabine—kidney cancer	0.000193	0.00112	CcSEcCtD
Dextropropoxyphene—Vomiting—Gemcitabine—kidney cancer	0.000191	0.00111	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—kidney cancer	0.000191	0.00111	CcSEcCtD
Dextropropoxyphene—Rash—Gemcitabine—kidney cancer	0.00019	0.0011	CcSEcCtD
Dextropropoxyphene—Dermatitis—Gemcitabine—kidney cancer	0.00019	0.0011	CcSEcCtD
Dextropropoxyphene—Headache—Gemcitabine—kidney cancer	0.000189	0.00109	CcSEcCtD
Dextropropoxyphene—Nausea—Vincristine—kidney cancer	0.000188	0.00109	CcSEcCtD
Dextropropoxyphene—Insomnia—Capecitabine—kidney cancer	0.000187	0.00108	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Paclitaxel—kidney cancer	0.000186	0.00108	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Capecitabine—kidney cancer	0.000184	0.00107	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Capecitabine—kidney cancer	0.000182	0.00105	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—kidney cancer	0.000181	0.00105	CcSEcCtD
Dextropropoxyphene—Asthenia—Paclitaxel—kidney cancer	0.000181	0.00105	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—PTGS2—kidney cancer	0.00018	0.0422	CrCbGaD
Dextropropoxyphene—Nausea—Gemcitabine—kidney cancer	0.000179	0.00104	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000179	0.00103	CcSEcCtD
Dextropropoxyphene—Constipation—Capecitabine—kidney cancer	0.000177	0.00102	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—kidney cancer	0.000175	0.00102	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—kidney cancer	0.000174	0.00101	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Paclitaxel—kidney cancer	0.000172	0.000999	CcSEcCtD
Dextropropoxyphene—Diphenhydramine—PTGS1—kidney cancer	0.000171	0.0401	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Capecitabine—kidney cancer	0.00017	0.000987	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—kidney cancer	0.000169	0.000982	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Capecitabine—kidney cancer	0.000169	0.00098	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—kidney cancer	0.000169	0.00098	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—kidney cancer	0.000168	0.000971	CcSEcCtD
Dextropropoxyphene—Dizziness—Paclitaxel—kidney cancer	0.000167	0.000965	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Capecitabine—kidney cancer	0.000163	0.000947	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—kidney cancer	0.000163	0.000946	CcSEcCtD
Dextropropoxyphene—Vomiting—Paclitaxel—kidney cancer	0.00016	0.000928	CcSEcCtD
Dextropropoxyphene—Rash—Paclitaxel—kidney cancer	0.000159	0.00092	CcSEcCtD
Dextropropoxyphene—Dermatitis—Paclitaxel—kidney cancer	0.000159	0.00092	CcSEcCtD
Dextropropoxyphene—Headache—Paclitaxel—kidney cancer	0.000158	0.000914	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—kidney cancer	0.000154	0.000892	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Capecitabine—kidney cancer	0.000152	0.000883	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP1A1—kidney cancer	0.000152	0.0358	CrCbGaD
Dextropropoxyphene—Agitation—Doxorubicin—kidney cancer	0.00015	0.000869	CcSEcCtD
Dextropropoxyphene—Nausea—Paclitaxel—kidney cancer	0.00015	0.000867	CcSEcCtD
Dextropropoxyphene—Asthenia—Capecitabine—kidney cancer	0.000148	0.00086	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—kidney cancer	0.000146	0.000849	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—kidney cancer	0.000144	0.000832	CcSEcCtD
Dextropropoxyphene—Propafenone—ABCB1—kidney cancer	0.000143	0.0335	CrCbGaD
Dextropropoxyphene—Convulsion—Doxorubicin—kidney cancer	0.000142	0.00082	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Capecitabine—kidney cancer	0.000141	0.00082	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—kidney cancer	0.000137	0.000796	CcSEcCtD
Dextropropoxyphene—Dizziness—Capecitabine—kidney cancer	0.000137	0.000792	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—kidney cancer	0.000134	0.000779	CcSEcCtD
Dextropropoxyphene—Vomiting—Capecitabine—kidney cancer	0.000131	0.000762	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—kidney cancer	0.000131	0.00076	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—kidney cancer	0.000131	0.000757	CcSEcCtD
Dextropropoxyphene—Rash—Capecitabine—kidney cancer	0.00013	0.000755	CcSEcCtD
Dextropropoxyphene—Dermatitis—Capecitabine—kidney cancer	0.00013	0.000755	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—kidney cancer	0.00013	0.000754	CcSEcCtD
Dextropropoxyphene—Headache—Capecitabine—kidney cancer	0.00013	0.00075	CcSEcCtD
Dextropropoxyphene—Bepridil—ABCB1—kidney cancer	0.000127	0.0299	CrCbGaD
Dextropropoxyphene—Hypotension—Doxorubicin—kidney cancer	0.000125	0.000722	CcSEcCtD
Dextropropoxyphene—Nausea—Capecitabine—kidney cancer	0.000123	0.000712	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—kidney cancer	0.000121	0.000698	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—kidney cancer	0.000119	0.000688	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—kidney cancer	0.000118	0.000686	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—kidney cancer	0.000117	0.00068	CcSEcCtD
Dextropropoxyphene—Fentanyl—ABCB1—kidney cancer	0.000117	0.0275	CrCbGaD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000115	0.000667	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—kidney cancer	0.000114	0.00066	CcSEcCtD
Dextropropoxyphene—Loperamide—ABCB1—kidney cancer	0.000113	0.0265	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—kidney cancer	0.00011	0.000636	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000109	0.000631	CcSEcCtD
Dextropropoxyphene—CYP2C8—renal system—kidney cancer	0.000108	0.0435	CbGeAlD
Dextropropoxyphene—Abdominal pain—Doxorubicin—kidney cancer	0.000105	0.00061	CcSEcCtD
Dextropropoxyphene—CYP2C8—kidney—kidney cancer	0.000104	0.0421	CbGeAlD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—kidney cancer	9.82e-05	0.000569	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—kidney cancer	9.56e-05	0.000554	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—kidney cancer	9.12e-05	0.000528	CcSEcCtD
Dextropropoxyphene—Dizziness—Doxorubicin—kidney cancer	8.81e-05	0.000511	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—kidney cancer	8.47e-05	0.000491	CcSEcCtD
Dextropropoxyphene—Trimipramine—ABCB1—kidney cancer	8.46e-05	0.0199	CrCbGaD
Dextropropoxyphene—Rash—Doxorubicin—kidney cancer	8.4e-05	0.000487	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—kidney cancer	8.4e-05	0.000486	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—kidney cancer	8.35e-05	0.000484	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ABCB1—kidney cancer	8.09e-05	0.019	CrCbGaD
Dextropropoxyphene—Methadone—ABCB1—kidney cancer	8.02e-05	0.0188	CrCbGaD
Dextropropoxyphene—Nausea—Doxorubicin—kidney cancer	7.92e-05	0.000459	CcSEcCtD
Dextropropoxyphene—CYP3A4—renal system—kidney cancer	7.3e-05	0.0295	CbGeAlD
Dextropropoxyphene—CYP2D6—renal system—kidney cancer	7.18e-05	0.029	CbGeAlD
Dextropropoxyphene—CYP3A4—kidney—kidney cancer	7.05e-05	0.0285	CbGeAlD
Dextropropoxyphene—CYP2D6—kidney—kidney cancer	6.94e-05	0.028	CbGeAlD
Dextropropoxyphene—OPRM1—Signaling Pathways—CTNNA1—kidney cancer	6.82e-06	0.000629	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—POMC—kidney cancer	6.82e-06	0.000629	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HSPB1—kidney cancer	6.78e-06	0.000626	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EIF4EBP1—kidney cancer	6.78e-06	0.000626	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GPC3—kidney cancer	6.77e-06	0.000624	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JUNB—kidney cancer	6.7e-06	0.000618	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PAK1—kidney cancer	6.7e-06	0.000618	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—SCARB1—kidney cancer	6.68e-06	0.000616	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CA2—kidney cancer	6.64e-06	0.000613	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS1—kidney cancer	6.62e-06	0.00061	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CA2—kidney cancer	6.59e-06	0.000607	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PSMD7—kidney cancer	6.49e-06	0.000598	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALAD—kidney cancer	6.47e-06	0.000597	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALAD—kidney cancer	6.42e-06	0.000592	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ST3GAL2—kidney cancer	6.32e-06	0.000583	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TSC1—kidney cancer	6.31e-06	0.000582	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PSMD7—kidney cancer	6.31e-06	0.000582	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ANXA1—kidney cancer	6.31e-06	0.000582	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PDHB—kidney cancer	6.27e-06	0.000578	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ST3GAL2—kidney cancer	6.26e-06	0.000578	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IGF2—kidney cancer	6.25e-06	0.000576	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—POMC—kidney cancer	6.25e-06	0.000576	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDKN2B—kidney cancer	6.22e-06	0.000574	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—POMC—kidney cancer	6.19e-06	0.000571	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALDH1A1—kidney cancer	6.18e-06	0.000569	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—BCHE—kidney cancer	6.15e-06	0.000567	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CA9—kidney cancer	6.13e-06	0.000565	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALDH1A1—kidney cancer	6.12e-06	0.000565	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FLT1—kidney cancer	6.11e-06	0.000563	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—SLC5A5—kidney cancer	6.08e-06	0.00056	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IGF1R—kidney cancer	6.04e-06	0.000557	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.99e-06	0.000553	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC5A3—kidney cancer	5.92e-06	0.000546	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PGK1—kidney cancer	5.92e-06	0.000546	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CCBL1—kidney cancer	5.89e-06	0.000543	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC5A3—kidney cancer	5.87e-06	0.000541	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PGK1—kidney cancer	5.87e-06	0.000541	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—SLC2A1—kidney cancer	5.87e-06	0.000541	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—RAF1—kidney cancer	5.82e-06	0.000537	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—LDHB—kidney cancer	5.81e-06	0.000535	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—POMC—kidney cancer	5.76e-06	0.000531	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—LDHB—kidney cancer	5.76e-06	0.000531	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—IL2—kidney cancer	5.75e-06	0.00053	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JUNB—kidney cancer	5.66e-06	0.000522	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PAK1—kidney cancer	5.66e-06	0.000522	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IGF2—kidney cancer	5.48e-06	0.000505	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN2B—kidney cancer	5.45e-06	0.000503	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IGF1R—kidney cancer	5.3e-06	0.000488	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—POMC—kidney cancer	5.23e-06	0.000482	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL2—kidney cancer	5.22e-06	0.000481	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CRABP1—kidney cancer	5.21e-06	0.000481	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GLIPR1—kidney cancer	5.11e-06	0.000471	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPAT—kidney cancer	5.11e-06	0.000471	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—RAF1—kidney cancer	5.1e-06	0.000471	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—IL2—kidney cancer	5.04e-06	0.000465	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CA9—kidney cancer	5.03e-06	0.000464	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CA9—kidney cancer	4.99e-06	0.00046	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HIF1A—kidney cancer	4.97e-06	0.000459	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TSC2—kidney cancer	4.96e-06	0.000457	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTP1—kidney cancer	4.89e-06	0.000451	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.88e-06	0.00045	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ITPR2—kidney cancer	4.85e-06	0.000447	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KDR—kidney cancer	4.76e-06	0.000439	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APRT—kidney cancer	4.75e-06	0.000438	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—FH—kidney cancer	4.75e-06	0.000438	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ABCB1—kidney cancer	4.63e-06	0.000427	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF2—kidney cancer	4.63e-06	0.000427	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	4.61e-06	0.000425	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL2—kidney cancer	4.58e-06	0.000422	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTM1—kidney cancer	4.5e-06	0.000415	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF1R—kidney cancer	4.48e-06	0.000413	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.47e-06	0.000412	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GPC3—kidney cancer	4.46e-06	0.000412	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ACHE—kidney cancer	4.42e-06	0.000408	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTT1—kidney cancer	4.42e-06	0.000408	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KIT—kidney cancer	4.38e-06	0.000404	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—APC—kidney cancer	4.38e-06	0.000404	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HIF1A—kidney cancer	4.36e-06	0.000402	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TSC2—kidney cancer	4.35e-06	0.000401	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CA2—kidney cancer	4.34e-06	0.0004	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—RAF1—kidney cancer	4.31e-06	0.000398	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CRABP1—kidney cancer	4.28e-06	0.000395	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CYP1A1—kidney cancer	4.26e-06	0.000393	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—IL2—kidney cancer	4.26e-06	0.000393	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CRABP1—kidney cancer	4.24e-06	0.000391	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALAD—kidney cancer	4.23e-06	0.00039	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—MAPK3—kidney cancer	4.2e-06	0.000387	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SCARB1—kidney cancer	4.18e-06	0.000386	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—POMC—kidney cancer	4.17e-06	0.000385	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KDR—kidney cancer	4.17e-06	0.000385	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS1—kidney cancer	4.14e-06	0.000382	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.13e-06	0.000381	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—BRAF—kidney cancer	4.12e-06	0.00038	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PSMD7—kidney cancer	4.06e-06	0.000375	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.04e-06	0.000372	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—MAPK1—kidney cancer	3.99e-06	0.000368	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ITPR2—kidney cancer	3.98e-06	0.000367	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ITPR2—kidney cancer	3.95e-06	0.000364	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PGK1—kidney cancer	3.87e-06	0.000357	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.87e-06	0.000357	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL2—kidney cancer	3.87e-06	0.000357	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—BCHE—kidney cancer	3.85e-06	0.000355	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—APC—kidney cancer	3.84e-06	0.000354	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KIT—kidney cancer	3.84e-06	0.000354	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—PIK3CA—kidney cancer	3.81e-06	0.000352	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.8e-06	0.000351	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LDHB—kidney cancer	3.8e-06	0.00035	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—KRAS—kidney cancer	3.77e-06	0.000348	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HIF1A—kidney cancer	3.69e-06	0.00034	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	3.68e-06	0.000339	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TSC2—kidney cancer	3.68e-06	0.000339	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.67e-06	0.000339	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—POMC—kidney cancer	3.66e-06	0.000337	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.64e-06	0.000335	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ACHE—kidney cancer	3.63e-06	0.000335	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTT1—kidney cancer	3.63e-06	0.000335	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—BRAF—kidney cancer	3.61e-06	0.000333	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ACHE—kidney cancer	3.6e-06	0.000332	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTT1—kidney cancer	3.6e-06	0.000332	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.56e-06	0.000329	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KDR—kidney cancer	3.52e-06	0.000325	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	3.5e-06	0.000323	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PIK3CA—kidney cancer	3.46e-06	0.000319	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RAF1—kidney cancer	3.44e-06	0.000317	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SCARB1—kidney cancer	3.44e-06	0.000317	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RELA—kidney cancer	3.42e-06	0.000316	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SCARB1—kidney cancer	3.41e-06	0.000314	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ERBB2—kidney cancer	3.4e-06	0.000314	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS1—kidney cancer	3.4e-06	0.000314	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS1—kidney cancer	3.37e-06	0.000311	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MTOR—kidney cancer	3.36e-06	0.00031	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	3.34e-06	0.000308	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PSMD7—kidney cancer	3.33e-06	0.000308	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—KRAS—kidney cancer	3.31e-06	0.000305	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PSMD7—kidney cancer	3.31e-06	0.000305	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CA9—kidney cancer	3.29e-06	0.000304	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KIT—kidney cancer	3.25e-06	0.000299	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APC—kidney cancer	3.25e-06	0.000299	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—POMC—kidney cancer	3.18e-06	0.000293	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—BCHE—kidney cancer	3.16e-06	0.000292	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDKN1B—kidney cancer	3.15e-06	0.00029	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—BCHE—kidney cancer	3.13e-06	0.000289	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.12e-06	0.000288	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	3.11e-06	0.000287	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.11e-06	0.000287	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.1e-06	0.000285	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—POMC—kidney cancer	3.09e-06	0.000285	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL2—kidney cancer	3.08e-06	0.000284	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTP1—kidney cancer	3.06e-06	0.000283	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—BRAF—kidney cancer	3.05e-06	0.000281	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	3.04e-06	0.00028	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.02e-06	0.000278	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RAF1—kidney cancer	3.01e-06	0.000278	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCND1—kidney cancer	3.01e-06	0.000277	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RELA—kidney cancer	3e-06	0.000277	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—JUN—kidney cancer	3e-06	0.000277	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.99e-06	0.000276	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ERBB2—kidney cancer	2.98e-06	0.000275	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CTNNB1—kidney cancer	2.98e-06	0.000274	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	2.96e-06	0.000273	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MTOR—kidney cancer	2.94e-06	0.000271	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.9e-06	0.000267	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PTEN—kidney cancer	2.9e-06	0.000267	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ABCB1—kidney cancer	2.9e-06	0.000267	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	2.83e-06	0.000261	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTM1—kidney cancer	2.82e-06	0.00026	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CRABP1—kidney cancer	2.8e-06	0.000258	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—KRAS—kidney cancer	2.79e-06	0.000258	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	2.76e-06	0.000255	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL2—kidney cancer	2.7e-06	0.000249	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.67e-06	0.000246	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCND1—kidney cancer	2.64e-06	0.000243	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JUN—kidney cancer	2.63e-06	0.000242	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—kidney cancer	2.62e-06	0.000242	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	2.61e-06	0.000241	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ITPR2—kidney cancer	2.6e-06	0.00024	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	2.57e-06	0.000237	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RAF1—kidney cancer	2.55e-06	0.000235	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PTEN—kidney cancer	2.54e-06	0.000235	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RELA—kidney cancer	2.54e-06	0.000234	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—kidney cancer	2.54e-06	0.000234	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.53e-06	0.000233	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ERBB2—kidney cancer	2.52e-06	0.000232	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTP1—kidney cancer	2.52e-06	0.000232	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTP1—kidney cancer	2.49e-06	0.00023	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MTOR—kidney cancer	2.49e-06	0.000229	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK3—kidney cancer	2.48e-06	0.000229	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MYC—kidney cancer	2.41e-06	0.000222	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ABCB1—kidney cancer	2.38e-06	0.00022	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTT1—kidney cancer	2.37e-06	0.000219	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ACHE—kidney cancer	2.37e-06	0.000219	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ABCB1—kidney cancer	2.36e-06	0.000218	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK1—kidney cancer	2.36e-06	0.000217	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	2.33e-06	0.000215	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTM1—kidney cancer	2.31e-06	0.000213	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—kidney cancer	2.3e-06	0.000212	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTM1—kidney cancer	2.29e-06	0.000211	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL2—kidney cancer	2.28e-06	0.000211	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SCARB1—kidney cancer	2.25e-06	0.000207	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KRAS—kidney cancer	2.23e-06	0.000205	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCND1—kidney cancer	2.23e-06	0.000205	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS1—kidney cancer	2.22e-06	0.000205	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JUN—kidney cancer	2.22e-06	0.000205	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTEN—kidney cancer	2.21e-06	0.000204	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	2.21e-06	0.000203	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.19e-06	0.000202	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.19e-06	0.000202	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PSMD7—kidney cancer	2.18e-06	0.000201	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK3—kidney cancer	2.17e-06	0.0002	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.17e-06	0.0002	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTEN—kidney cancer	2.15e-06	0.000198	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MYC—kidney cancer	2.11e-06	0.000195	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK1—kidney cancer	2.07e-06	0.000191	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—BCHE—kidney cancer	2.07e-06	0.000191	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CA—kidney cancer	2.05e-06	0.000189	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.04e-06	0.000188	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—POMC—kidney cancer	1.99e-06	0.000184	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—kidney cancer	1.98e-06	0.000183	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.97e-06	0.000182	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KRAS—kidney cancer	1.95e-06	0.00018	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—kidney cancer	1.94e-06	0.000179	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK3—kidney cancer	1.84e-06	0.000169	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	1.79e-06	0.000165	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MYC—kidney cancer	1.79e-06	0.000165	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.78e-06	0.000165	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK1—kidney cancer	1.75e-06	0.000161	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—kidney cancer	1.74e-06	0.00016	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KRAS—kidney cancer	1.65e-06	0.000152	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTP1—kidney cancer	1.64e-06	0.000152	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—POMC—kidney cancer	1.63e-06	0.000151	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—POMC—kidney cancer	1.62e-06	0.000149	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—kidney cancer	1.59e-06	0.000146	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.56e-06	0.000144	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCB1—kidney cancer	1.56e-06	0.000144	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	1.52e-06	0.00014	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTM1—kidney cancer	1.51e-06	0.000139	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—kidney cancer	1.47e-06	0.000135	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.43e-06	0.000132	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTEN—kidney cancer	1.38e-06	0.000128	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—kidney cancer	1.3e-06	0.00012	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—kidney cancer	1.29e-06	0.000119	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTEN—kidney cancer	1.14e-06	0.000105	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTEN—kidney cancer	1.13e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—POMC—kidney cancer	1.07e-06	9.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CA—kidney cancer	9.77e-07	9.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—kidney cancer	8.52e-07	7.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CA—kidney cancer	8.02e-07	7.39e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CA—kidney cancer	7.95e-07	7.33e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTEN—kidney cancer	7.43e-07	6.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.24e-07	4.83e-05	CbGpPWpGaD
